Molecular profiling of hormone receptor-positive,HER2-negative breast cancers from patients treated with neoadjuvant endocrine therapy in the CARMINA 02 trial (UCBG-0609)期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

按检索

Molecular profiling of hormone receptor-positive,HER2-negative breast cancers from patients treated with neoadjuvant endocrine therapy in the CARMINA 02 trial (UCBG-0609)

Authors:	Xu Liang Adrien Briaux Véronique Becette Camille Benoist Anais Boulai Walid Chemlali Anne Schnitzler Sylvain Baulande Sofia Rivera Marie-Ange Mouret-Reynier Laurence Venat Bouvet Thibaut De La Motte Rouge Jérôme Lemonnier Florence Lerebours Céline Callens

Institution:	1.Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Breast Oncology,Peking University Cancer Hospital & Institute,Beijing,China;2.Pharmacogenomic Unit, Department of Genetics, Curie Institute,PSL Research University,Paris,France;3.Department of Biopathology, Curie Institute,René Huguenin Hospital,Saint-Cloud,France;4.Institut Curie Genomics of Excellence (ICGex) Platform, Curie Institute,PSL Research University,Paris,France;5.Department of Radiotherapy, Gustave Roussy,Villejuif,France;6.Department of Medical Oncology, Centre Jean Perrin,Clermont-Ferrand,France;7.Department of Medical Oncology, CHU,Limoges,France;8.Department of Medical Oncology, Centre Eugene Marquis,Rennes,France;9.R&D Unicancer, UCBG,Paris,France;10.Department of Medical Oncology, Curie Institute,René Huguenin Hospital,Saint-Cloud,France

Abstract:

Keywords:
本文献已被 SpringerLink 等数据库收录！